A new Listerine product is making a big splash after a short time on the market

Article Abstract:

Listerine's new Listerine Pocket Paks, paper-thin strips that melt on the tongue, are selling well after a short time on the market. Pfizer has distributed Pocket Paks at the Emmys, at Manhattan movie theaters, at the Chicago Film Festival and the Head of the Charles regatta, and will distribute even more at the Oscars and the Golden Globes.

Pharmaceutical Preparation Manufacturing, Toilet Preparation Manufacturing, Advertising, Toilet preparations, Marketing/Advertising Methods, Pharmaceutical Preparations, Mouthwashes, Drugs, Marketing, Toiletries industry

---

New Study Links Pfizer's Bextra, Similar to Vioxx, To Heart Attacks

Article Abstract:

Preliminary data from a new clinical study, show that Bextra, a Cox-2 inhibitor from Pfizer Inc., more than doubled the number of heart attacks or strokes in patients. The results are similar to those reported in studies of another Cox-2 inhibitor, Vioxx, from Merck and Company, which was taken off the market in September.

Product standards, safety, & recalls, Financial management, Science & research, Securities issued, listed, Research, Product defects and recalls, Finance, Reports, Risk factors, Clinical trials, Securities, Heart diseases, COX-2 inhibitors, Company securities, Company financing, American Heart Association, Vioxx (Medication), Merck & Company Inc.

---

F.D.A. Urges Doctors to Limit Their Prescriptions for a Pair of Popular Painkillers

Article Abstract:

The Food and Drug Administration is planning to convene an advisory group to determine whether painkillers Bextra and Celebrex, both from Pfizer Inc., should be taken off the market. In the meantime, the agency is recommending that doctors limit prescribing the drugs.

Legal issues & crime, Government regulation (cont), Government regulation, Legal/Government Regulation, Laws, regulations and rules, Nonsteroidal anti-inflammatory drugs, Nonsteroidal anti-inflammatory agents, Dosage and administration, United States. Food and Drug Administration, Celebrex (Medication)

Similar abstracts:

• Abstracts: Prototypes of new chip from Japan: product may become a standard in a market. Executives say Japanese may be dumping chips
• Abstracts: Japan's mini invasions. Warriors from the North. Bringing up the rear
• Abstracts: The next best thing. On the margins no more. The opposite tax
• Abstracts: Air Canada survival plan eyed. Airline's value seen as $2-billiion. Airline seeks to thwart Tango
• Abstracts: Air Canada seeks rapid approval: asks judge to okay equity deal, setting stage for legal battle with creditors, unions

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.